Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chemokine receptor binding heterocyclic compounds

Chemokine receptor binding heterocyclic compounds

US Patent 7629337 · Granted Dec 8, 2009

Estimated economic value: $114,275,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and u2025
Anti-bacterial stilbene derivatives and methods of use2025
Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activators2024
Glucosylceramide synthase inhibitors2024
Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical2024
Heterologous production of leupeptin protease inhibitors and analogs thereof2024
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, re2024
CXCR4 inhibitors and uses thereof2023
Indene derivatives useful in treating pain and inflammation2023
Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment o2022
Indene derivatives useful in treating pain and inflammation2022
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical 2022